A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Completed · Phase 2

Conditions studied: HIV Infections

In brief

HIV infected children and adolescents who have taken many anti-HIV drugs may have limited treatment options and are at high risk for progressing to AIDS. The purpose of this study is to determine whether an anti-HIV treatment regimen of 2 protease inhibitors (PIs) and 2 nucleoside reverse transcriptase inhibitors (NRTIs) is more effective than a regimen of 4 NRTIs in treatment-experienced children and adolescents who have failed previous anti-HIV treatment.

Key facts

Study ID

NCT00102206

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

6

Expected to finish

2007-05-01

Last updated by the study team

2021-11-01

Who can join

Age: 4 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Chicago Children's CRS — Chicago, Illinois, United States
• Columbia IMPAACT CRS — New York, New York, United States
• SUNY Stony Brook NICHD CRS — Stony Brook, New York, United States
• DUMC Ped. CRS — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.